- Question from beth_Popadynetz: What was the most significant news at the San Antonio Breast Cancer Symposium?
- Answers - Eric Winer, M.D. I think the most exciting news was about the potential for some new anti-HER2 therapies, although none of these was ready for routine clinical use. I think the two most clinically relevant pieces of information were that (1) we should not be doing CYP2D6 tests to select hormonal therapies as a matter of practice, and (2) the bisphosphonates in the most recent study do not seem to prevent breast cancer recurrence.
The Ask-the-Expert Online Conference called Updates From the 2010 San Antonio Breast Cancer Symposium featured Eric Winer, M.D. and Marisa Weiss, M.D. answering your questions about the latest updates on breast cancer risk, screening, and treatment in early and metastatic breast cancer.
Editor's Note: This conference took place in December 2010.
The materials presented in these conferences do not necessarily reflect the views of Breastcancer.org. A qualified healthcare professional should be consulted before using any therapeutic product or regimen discussed. All readers should verify all information and data before employing any therapies described here.
A production of LiveWorld, Inc.
Copyright 2010. All rights reserved.